DB
SRRA

Dmitry Balyasny’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Dmitry Balyasny’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210,923
Closed -$11.6M – 3480
2022
Q2 		$11.6M Buy
+210,923
New +$11.1M 0.04% 605

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Dmitry Balyasny's SRRA Position: Q3 2022 in Review

Dmitry Balyasny sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 210,923 shares — an estimated $11.6M sold.

Dmitry Balyasny first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $11.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Dmitry Balyasny reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 210,923 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $11.6M.
  • Dmitry Balyasny first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Dmitry Balyasny's Sierra Oncology, Inc. Common Stock position peaked at $11.6M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.